blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2027866

EP2027866 - Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  13.03.2015
Database last updated on 07.10.2024
Most recent event   Tooltip13.03.2015Withdrawal of applicationpublished on 15.04.2015  [2015/16]
Applicant(s)For all designated states
Oncolytics Biotech Inc.
Suite 210 1167 Kensington Crescent N. W.
Calgary, AB T2N 1X7 / CA
[2009/09]
Inventor(s)01 / Coffey, Matthew
2231 Bowness Road, N.W.
Calgary, Alberta T2N 3L4 / CA
02 / Thompson, Bradley
1775 7th Avenue, N.W.
Calgary, Alberta T2N 0Z5 / CA
 [2009/09]
Representative(s)Nash, David Allan, et al
Haseltine Lake LLP
Redcliff Quay
120 Redcliff Street
Bristol BS1 6HU / GB
[2014/01]
Former [2009/09]Vossius & Partner
Siebertstrasse 4
81675 München / DE
Application number, filing date08006359.720.07.2001
[2009/09]
Priority number, dateUS2000063659710.08.2000         Original published format: US 636597
[2009/09]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2027866
Date:25.02.2009
Language:EN
[2009/09]
Search report(s)(Supplementary) European search report - dispatched on:EP30.12.2008
ClassificationIPC:A61K35/76, A61P35/00
[2009/09]
CPC:
A61K35/765 (EP,US); A61K38/13 (EP,US); A61P1/00 (EP);
A61P1/16 (EP); A61P1/18 (EP); A61P11/00 (EP);
A61P13/08 (EP); A61P13/12 (EP); A61P15/00 (EP);
A61P25/00 (EP); A61P31/12 (EP); A61P35/00 (EP);
A61P43/00 (EP); A61P7/00 (EP); C07K16/081 (EP,US);
C07K16/10 (EP,US); C07K16/4216 (EP,US); C12N9/1205 (EP,US);
C12N2720/12232 (EP,US); Y10S435/948 (EP,US); Y10S435/975 (EP,US) (-)
C-Set:
A61K35/765, A61K2300/00 (EP,US);
A61K38/13, A61K2300/00 (US,EP)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2009/09]
TitleGerman:Methoden zur Prävention der Reovirus-Erkennung zur Behandlung von zellulären proliferativen Erkrankungen[2009/09]
English:Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders[2009/09]
French:Méthodes pour la prévention de la reconnaissance du réovirus pour le traitement des maladies cellulaires prolifératives[2009/09]
Examination procedure25.08.2009Amendment by applicant (claims and/or description)
25.08.2009Examination requested  [2009/46]
01.10.2013Despatch of a communication from the examining division (Time limit: M04)
30.01.2014Reply to a communication from the examining division
05.03.2015Application withdrawn by applicant  [2015/16]
06.03.2015Cancellation of oral proceeding that was planned for 14.04.2015
14.04.2015Date of oral proceedings (cancelled)
Parent application(s)   TooltipEP01953727.3  / EP1309334
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20010953727) is  17.09.2003
Fees paidRenewal fee
31.03.2008Renewal fee patent year 03
31.03.2008Renewal fee patent year 04
31.03.2008Renewal fee patent year 05
31.03.2008Renewal fee patent year 06
31.03.2008Renewal fee patent year 07
31.03.2008Renewal fee patent year 08
28.07.2009Renewal fee patent year 09
26.07.2010Renewal fee patent year 10
12.07.2011Renewal fee patent year 11
13.07.2012Renewal fee patent year 12
10.07.2013Renewal fee patent year 13
14.07.2014Renewal fee patent year 14
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[DY]WO9908692  (LEE PATRICK W K [CA], et al);
by applicantWO9908692
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.